{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:55:52Z","timestamp":1791996952287,"version":"4.4.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Implantation of durable left ventricular assist device (LVAD) in cardiogenic shock (CS) patients after acute myocardial infarction (AMI) poses specific challenges (small left ventricular size, acute infarct area, need for antithrombotic therapy, status Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 with impaired organ function and derangements in coagulation and inflammatory parameters) which may affect outcomes. We reviewed data of all AMI-CS patients who were implanted LVAD after Impella support at a referral center with the aim to analyze feasibility, timing, and outcomes of durable LVAD implantation after tMCS with Impella due to AMI-CS. Twenty-one patients were treated between 2013 and 2023: all were in Society for Cardiovascular Angiography &amp; Interventions (SCAI) class D\u2013E and INTERMACS 1\u20132 at presentation, median LV ejection fraction (EF) and LV end-diastolic diameter (EDD) were 15 (10\u201320)% and 57 (54\u201360) mm, respectively. Eleven patients (52%) were supported with Impella CP, seven with Impella 5.0 (33%), and three (14%) with Impella 2.5. Axillary cannulation was performed in nine patients (43%). Five patients (24%) had concomitant venoarterial extracorporeal membrane oxygenation (VA-ECMO) support. Median duration of Impella support was 12 (8\u201314) days. Overall, the use of Impella was characterized by low rate of complications and allowed successful bridge to durable LVAD in all patients, with 100% 30 day survival rate.<\/jats:p>","DOI":"10.1097\/mat.0000000000002201","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T22:31:17Z","timestamp":1711578677000},"page":"e150-e152","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Impella as Bridge to Durable Left Ventricular Assist Device in Acute Myocardial Infarction Cardiogenic Shock Patients"],"prefix":"10.1097","volume":"70","author":[{"given":"Silvia","family":"Ajello","sequence":"first","affiliation":[{"name":"Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-800X","authenticated-orcid":false,"given":"Marina","family":"Pieri","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy"},{"name":"School of Medicine, Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dormio","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldetti","sequence":"additional","affiliation":[{"name":"Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Altizio","sequence":"additional","affiliation":[{"name":"Cardiac Intensive Care Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Consolo","sequence":"additional","affiliation":[{"name":"School of Medicine, Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Nardelli","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ortalda","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mara","family":"Scandroglio","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"R1-20250530","doi-asserted-by":"crossref","first-page":"I32","DOI":"10.1093\/eurheartjsupp\/suad131","article-title":"Differential utilization of Impella devices, extracorporeal membrane oxygenation, and combined therapies as escalation and de-escalation strategies.","volume":"25","author":"Bernhardt","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"R2-20250530","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2019.12.028","article-title":"Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.","volume":"57","author":"Bertoldi","year":"2020","journal-title":"J Crit Care"},{"key":"R3-20250530","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/aor.12168","article-title":"Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices.","volume":"38","author":"Pieri","year":"2014","journal-title":"Artif Organs"},{"key":"R4-20250530","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2013.10.004","article-title":"Anticoagulation for critically ill cardiac surgery patients: is primary bivalirudin the next step?","volume":"28","author":"Pappalardo","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R5-20250530","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/MAT.0000000000001871","article-title":"Anti-thrombotic therapy with cangrelor and bivalirudin in venoarterial extracorporeal membrane oxygenation patients undergoing percutaneous coronary intervention: a single-center experience.","volume":"69","author":"Baldetti","year":"2023","journal-title":"ASAIO J"},{"key":"R6-20250530","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2022.02.052","article-title":"Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock: JACC Review Topic of the Week.","volume":"79","author":"Vandenbriele","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250530","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.athoracsur.2019.01.061","article-title":"Impact of bleeding revision on outcomes after left ventricular assist device implantation.","volume":"108","author":"Angleitner","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R8-20250530","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R9-20250530","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2020.03.010","article-title":"Updated definitions of adverse events for trials and registries of mechanical circulatory support: a consensus statement of the mechanical circulatory support academic research consortium.","volume":"39","author":"Kormos","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R10-20250530","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cardfail.2017.09.011","article-title":"Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: An INTERMACS analysis.","volume":"23","author":"Patel","year":"2017","journal-title":"J Card Fail"},{"key":"R11-20250530","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/MAT.0000000000001974","article-title":"Four-factor prothrombin complex concentrate in left ventricular assist device implantation: Inverse propensity score-weighted analysis.","volume":"69","author":"Monaco","year":"2023","journal-title":"ASAIO J"},{"key":"R12-20250530","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jocs.15401","article-title":"Impact of a surgical approach for implantation of durable left ventricular assist devices in patients on extracorporeal life support.","volume":"36","author":"Potapov","year":"2021","journal-title":"J Card Surg"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000002201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:02:09Z","timestamp":1748610129000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0000000000002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000002201","relation":{},"ISSN":["1058-2916","1538-943X"],"issn-type":[{"value":"1058-2916","type":"print"},{"value":"1538-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]}}}